SENSEX
NIFTY
GOLD
USD/INR

Weather

image 21    C

Markets News

The Economic Times

Markets / The Economic Times

details

US Stocks: Apellis shares double on Biogen's $5.6 billion buyout plan

Biogen will buy Apellis Pharmaceuticals for about $5.6 billion, adding a promising kidney disease drug to broaden its rare-disease portfolio amid efforts to diversify beyond its slowing multiple sclerosis franchise.

31 Mar 2026 8:50 pm